跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEFTRIAXONE INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CEFTRIAXONE INJECTION, USP
Authorized
STANDARD
CEFTRIAXONE INJECTION, USP
baxter corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
651f2e6a564c15f2
Company
baxter corporation
Type
Standard
Approval Details
Approval Id
651f2e6a564c15f2
Drug Approval Canada Name
CEFTRIAXONE INJECTION, USP
Product Name
CEFTRIAXONE INJECTION, USP
Status
Marketed
Status Date
2021-03-18
Original Market Date
2021-03-18
Din
02499738
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.06.12
Atc Original
J01DD04 CEFTRIAXONE
Atc Name
j 01 dd 04
Aig Number
0117292012
Company Name
baxter corporation
Company Address
7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2
Active Ingredients
CEFTRIAXONE (CEFTRIAXONE SODIUM)
2000 MG / 50 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
651f2e6a564c15f2
Type
Standard
Back to Health Canada Approvals